Advertisement

CSF glutamate/GABA concentrations in pyridoxine-dependent seizures: etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control

      Abstract

      Several lines of evidence suggest that the binding affinity of glutamate decarboxylase (GAD) to the active form of pyridoxine is low in cases of pyridoxine-dependent seizures (PDS) and that a quantitative imbalance between excitatory (i.e. glutamate) and inhibitory (i.e. γ-aminobutyric acid, GABA) neurotransmitters could cause refractory seizures. However, inconsistent findings with GAD insufficiency have been reported in PDS. We report a case of PDS that is not accompanied by an elevated cerebrospinal fluid (CSF) glutamate concentration. Intravenous pyridoxine phosphate terminated generalized seizures which were otherwise refractory to conventional anti-epileptic medicines. No seizure occurred once oral pyridoxine (13.5 mg/kg per day) was started in combination with phenobarbital sodium (PB, 3.7 mg/kg per day). The electroencephalogram (EEG) normalized approximately 8 months after pyridoxine was started. The patient is gradually acquiring developmental milestones during the 15 months follow-up period. The CSF glutamate and GABA concentrations were determined on three separate occasions: (1) during status epilepticus; (2) during a seizure-free period with administration of pyridoxine and PB; and (3) 6 days after suspension of pyridoxine and PB and immediately before a convulsion. The CSF glutamate level was below the sensitivity of detection (<1.0 μM) on each of the three occasions; the CSF GABA level was within the normal range or moderately elevated. The CSF and serum concentrations of vitamin B6-related substances, before pyridoxine supplementation, were within the normal range. We suggest that (1) PDS is not a discrete disease of single etiology in that insufficient activation of GAD may not account for seizure susceptibility in all cases and (2) mechanism(s) of anti-convulsive effect of pyridoxine, at least in some cases, may be independent of GAD activation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hunt A
        • Storkes J
        • McCrory W
        • Striud H
        Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine.
        Pediatrics. 1954; 13: 140-143
        • Bankier A
        • Turner M
        • Hopkins I.J
        Pyridoxine dependent seizures – a wider clinical spectrum.
        Arch Dis Child. 1983; 58: 415-418
        • Haenggeli C.A
        • Giradin E
        • Paunier L
        Pyridoxine-dependent seizures, clinical and therapeutic aspects.
        Eur J Pediatr. 1991; 150: 452-455
        • Gospe Jr., S.M
        Current perspectives on pyridoxine-dependent seizures.
        J Pediatr. 1998; 132: 919-923
        • Yoshida T
        • Tada K
        • Arakawa T
        Vitamin B6 dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin B6 dependent convulsion.
        Tohoku J Exp Med. 1971; 104: 195-198
        • Gospe Jr., S.M
        • Olin K.L
        • Keen C.L
        Reduced GABA synthesis in pyridoxine-dependent seizures.
        Lancet. 1994; 343: 1133-1134
        • Kurlemann G
        • Ziegler R
        • Grüneberg M
        • Bömelburg T
        • Ullrich K
        • Palm D.G
        Disturbance of GABA metabolism in pyridoxine-dependent seizures.
        Neuropediatrics. 1992; 23: 257-259
        • Lott I.T
        • Coulombe T
        • Di Paolo R.V
        • Richardson Jr., E.P
        • Levy H.L
        Vitamin B6-dependent seizures: pathology and chemical findings in brain.
        Neurology. 1978; 28: 47-54
        • Baumeister F.A
        • Gsell W
        • Shin Y.S
        • Egger J
        Glutamate in pyridoxine-dependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine.
        Pediatrics. 1994; 94: 318-321
        • Kure S
        • Maeda T
        • Fukushima N
        • Ohura T
        • Takahashi K
        • Nishikawa T
        • et al.
        A subtype of pyridoxine-dependent epilepsy with normal CSF glutamate concentration.
        J Inher Metab Dis. 1998; 21: 431-432
        • Kure S
        • Sakata Y
        • Miyabayashi S
        • Takahashi K
        • Shinka T
        • Matsubara Y
        • et al.
        Mutation and polymorphic marker analyses of 65K- and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent epilepsy.
        J Hum Genet. 1998; 43: 128-131
        • Scriver C.R
        Vitamin B6 deficiency and dependency in man.
        Am J Dis Child. 1967; 113: 109-114
        • Pascal T.A
        • Gaull G.E
        • Beratis N.G
        • Gillam B.M
        • Tallan H.H
        • Hirschhorn K
        Vitamin B6-responsive and -unresponsive cystathioninuria: two variant molecular forms.
        Science. 1975; 190: 1209-1211
        • Berson E.L
        • Shih V.E
        • Sullivan P.L
        Ocular findings in patients with gyrate atrophy on pyridoxine and low-protein, low-arginine diets.
        Ophthalmology. 1981; 88: 311-315
        • Weleber R.G
        • Kennaway N.G
        Clinical trial of vitamin B6 for gyrate atrophy of the choroid and retina.
        Ophthalmology. 1981; 88: 316-324
        • Hayasaka S
        • Saito T
        • Nakajima H
        • Takaku Y
        • Shiono T
        • Mizuno K
        • et al.
        Gyrate atrophy with hyperornithinaemia: different types of responsiveness to vitamin B6.
        Br J Ophthalmol. 1981; 65: 478-483
        • Behrman R.E
        • Kliegman R.M
        • Arvin A.M
        Nelson textbook of pediatrics. 15th ed. W.B. Saunders, Philadelphia, PA1996
        • Swaiman K.F
        • Ashwal S
        Pediatric neurology. Principles & practice. 3rd ed. Mosby, St. Louis, MO1999
        • Kaufman D.L
        • Houser C.R
        • Tobin A.J
        Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions.
        J Neurochem. 1991; 56: 720-723
        • Bu D.F
        • Erlander M.G
        • Hitz B.C
        • Tillakaratne N.J
        • Kaufman D.L
        • Wagner-McPherson C.B
        • et al.
        Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene.
        Proc Natl Acad Sci USA. 1992; 89: 2115-2119
        • Asada H
        • Kawamura Y
        • Maruyama K
        • Kume H
        • Ding R
        • Ji F.Y
        • et al.
        Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal level of GAD67 and GABA in their brains but are susceptible to seizures.
        Biochem Biophys Res Commun. 1996; 229: 891-895
        • Asada H
        • Kawamura Y
        • Maruyama K
        • Kume H
        • Ding R.G
        • Kanbara N
        • et al.
        Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase.
        Proc Natl Acad Sci USA. 1997; 94: 6496-6499
        • Condie B.G
        • Bain G
        • Gottlieb D.I
        • Capecchi M.R
        Cleft palate in mice with a targeted mutation in the γ-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67.
        Proc Natl Acad Sci USA. 1997; 94: 11451-11455
        • Kash S.F
        • Johnson R.S
        • Tecott L.H
        • Noebels J.L
        • Mayfield R.D
        • Hanahan D
        • et al.
        Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.
        Proc Natl Acad Sci USA. 1997; 94: 14060-14065
        • Uhlendorf B.W
        • Conerly E.B
        • Mudd S.H
        Homocystinuria: studies in tissue culture.
        Pediatr Res. 1973; 7: 645-658
        • Wong R.K
        • Miles R
        • Traub R.D
        Local circuit interactions in synchronization of cortical neurones.
        J Exp Biol. 1984; 112: 169-178
        • Kandel E.R
        • Schwartz J.H
        • Jessel T.M
        Principles of neural science. 4th ed. Appleton & Lange, Norwalk, CT1999
        • Kurlemann G
        • Löscher W
        • Dominick H.C
        • Palm G.D
        Disappearance of neonatal seizures and low CSF GABA levels after treatment with vitamin B6.
        Epilepsy Res. 1987; 1: 152-154
        • Kurlemann G
        • Deufel T
        • Schuierer G
        Pyridoxine-responsive West syndrome and gamma-aminobutyric acid.
        Eur J Pediatr. 1997; 156: 158-159
        • Ito M
        • Mikawa H
        • Taniguchi T
        Cerebrospinal fluid GABA levels in children with infantile spasms.
        Neurology. 1984; 34: 235-238
        • Aicardi J
        Diseases of the nervous system in childhood. 2nd ed. Mac Keith Press, London1998
        • Tada H
        Glutamic acid decarboxylase in cerebrospinal fluid in infancy and childhood. Part I. Glutamic acid decarboxylase activity in cerebrospinal fluid of normal infants and children.
        Brain Dev. 1983; 5: 483-487
        • Vanderwinden J.M
        • Mailleux P
        • Schiffmann S.N
        • Vanderhaeghen J.J
        • DeLaet M.H
        Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis.
        N Engl J Med. 1992; 327: 511-515
        • Goldsmith R.F
        • Earl J.W
        • Cunningham A.M
        Determination of δ-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography.
        Clin Chem. 1987; 33: 1736-1740
        • Gerrits G.P
        • Trijbels F.J
        • Monnens L.A
        • Gabreëls F.J
        • De Abreu R.A
        • Theeuwes A.G
        • et al.
        Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection.
        Clin Chim Acta. 1989; 182: 271-280
        • Spink D.C
        • Swann J.W
        • Snead O.C
        • Waniewski R.A
        • Martin D.L
        Analysis of aspartate and glutamate in human cerebrospinal fluid by high-performance liquid chromatography with automated precolumn derivatization.
        Anal Biochem. 1986; 158: 79-86
        • Yurdakök M
        • Coşkun T
        • Erdem G
        • Göktoǧan Ş
        • Özalp İ
        • Tekinalp G
        Cerebrospinal fluid amino acid levels in newborn infants with intracranial hemorrhage.
        Acta Paediatr Jpn. 1995; 37: 694-696
        • Carchon H.A
        • Jaeken J
        • Jansen E
        • Eggermont E
        Reference values for free gamma-aminobutyric acid determined by ion-exchange chromatography and fluorescence detection in the cerebrospinal fluid of children.
        Clin Chim Acta. 1991; 201: 83-88
        • Kurlemann G
        • Menges E.M
        • Palm D.G
        Low level of GABA in CSF in vitamin B6-dependent seizures.
        Dev Med Child Neurol. 1991; 33: 749-750